We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+17.61%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$10.6B
AUM Growth
+$1.44B
Cap. Flow
+$92.7M
Cap. Flow %
0.88%
Top 10 Hldgs %
22.72%
Holding
2,357
New
64
Increased
127
Reduced
1,296
Closed
88

Sector Composition

Rank Sector Weight
1 Technology 20.97%
2 Healthcare 12.78%
3 Financials 12.6%
4 Consumer Discretionary 11.75%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBMS
1751
DELISTED
The First Bancshares, Inc.
FBMS
$310K ﹤0.01%
10,042
LMAT icon
1752
LeMaitre Vascular
LMAT
$1.88B
$310K ﹤0.01%
7,651
CSTL icon
1753
Castle Biosciences
CSTL
$951M
$309K ﹤0.01%
4,608
TBBK icon
1754
The Bancorp
TBBK
$2.84B
$309K ﹤0.01%
22,607
KLRS
1755
Kalaris Therapeutics
KLRS
$95.2M
$308K ﹤0.01%
349
HIBB
1756
DELISTED
Hibbett, Inc. Common Stock
HIBB
$308K ﹤0.01%
6,677
KELYA icon
1757
Kelly Services Class A
KELYA
$546M
$307K ﹤0.01%
14,944
BOOM icon
1758
DMC Global
BOOM
$154M
$307K ﹤0.01%
7,096
RPT
1759
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$307K ﹤0.01%
35,465
+512
+1% +$3.46K
KDMN
1760
DELISTED
Kadmon Holdings, Inc.
KDMN
$306K ﹤0.01%
73,755
+20
+0% +$79
ICHR icon
1761
Ichor Holdings
ICHR
$2.73B
$306K ﹤0.01%
10,143
MYE icon
1762
Myers Industries
MYE
$1.27B
$305K ﹤0.01%
14,676
SP
1763
DELISTED
SP Plus Corporation
SP
$305K ﹤0.01%
10,567
NTUS
1764
DELISTED
Natus Medical Inc
NTUS
$304K ﹤0.01%
15,157
QADA
1765
DELISTED
QAD Inc.
QADA
$303K ﹤0.01%
4,798
OSG
1766
Octave Specialty Group
OSG
$208M
$303K ﹤0.01%
19,701
-2,743
-12% -$40.4K
CAC icon
1767
Camden National
CAC
$997M
$303K ﹤0.01%
8,459
PETS icon
1768
PetMed Express
PETS
$41.9M
$303K ﹤0.01%
9,436
BRKL
1769
DELISTED
Brookline Bancorp
BRKL
$301K ﹤0.01%
25,036
-1,855
-7% -$20.1K
OSUR icon
1770
OraSure Technologies
OSUR
$272M
$301K ﹤0.01%
28,446
VERI icon
1771
Veritone
VERI
$137M
$301K ﹤0.01%
+10,577
New +$183K
INVA icon
1772
Innoviva
INVA
$1.5B
$299K ﹤0.01%
24,098
-9,236
-28% -$99.6K
VREX icon
1773
Varex Imaging
VREX
$781M
$298K ﹤0.01%
17,885
NARI
1774
DELISTED
Inari Medical, Inc. Common Stock
NARI
$297K ﹤0.01%
3,408
HY icon
1775
Hyster-Yale Materials Handling
HY
$622M
$296K ﹤0.01%
4,976

Similar funds

MetLife Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, MetLife Investment Management held 2,357 positions worth $10.6B, up 16% from $9.13B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q4 2020 filing shows 64 new, 127 increased, 1,296 reduced and 88 closed positions. Its largest new stake was Vanguard Short-Term Bond ETF: 4,766,514 shares worth $395M. The largest sale was Apple, an estimated $23.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2020 buy was Vanguard Short-Term Bond ETF: 4,766,514 shares worth $395M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $23M increase.
  • MetLife Investment Management's biggest Q4 2020 reduction was Apple, cutting an estimated $23.3M.
  • MetLife Investment Management fully exited Dunkin' Brands Group, Inc. in Q4 2020, selling an estimated $3.86M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $10.6B portfolio in Q4 2020.
  • MetLife Investment Management opened 64 new positions and closed 88 in Q4 2020.
  • MetLife Investment Management's portfolio value rose 16% quarter-over-quarter to $10.6B.

Based on MetLife Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.